fever, skin rash and aseptic organ inflammation, and may be complicated by metabolic abnormalities (for example, 30% of patients with TRAPS develop amyloidosis) 1, 3 . Patients with these diseases are not generally prone to unusual infectious diseases with the exception of PLCG2-deficient patients reported recently 4 . In sharp contrast, inborn errors that decrease TNF-mediated and IL-1β-mediated immunity are associated with severe infectious diseases in the context of impaired inflammation. Inborn errors of NF-κB-mediated immunity are associated with impaired cellular responses to various stimuli, including TNF and IL-1β; these diseases include X-linked recessive and autosomal dominant anhidrotic ectodermal dysplasia with immunodeficiency owing to hypomorphic mutations of the NF-κB essential modulator (NEMO, also known as IKBKG) gene and hypermorphic mutations of the IKBA (also known as NFKBIA) gene, respectively [5] [6] [7] [8] . Defects restricted to the pathway involving Toll-like receptor (TLR) and IL-1 receptor (IL-1R), collectively defined as the Toll-like and interleukin 1 receptor (TIR) pathway, which affect the NF-κB, IRF3 and MAPK signaling molecules, include autosomal-recessive IRAK-4 and autosomal-recessive MyD88 deficiencies [8] [9] [10] [11] [12] [13] . Patients with these two deficiencies are prone to the development of life-threatening pyogenic bacterial diseases 11 . The range of infections is much broader in patients with NEMO and IκBα mutations 14 . A characteristic of these four inborn errors of immunity is that clinical and biological signs of inflammation are absent or delayed during infectious episodes, although they may reach normal levels during prolonged infection 14 . For example, the induction of IL-6-dependent C-reactive protein (CRP) is impaired in these patients 11, 15 .
We report here the description and investigation of three patients from two unrelated families displaying a paradoxical clinical phenotype combining autoinflammatory syndrome and pyogenic bacterial diseases. These patients also developed muscular amylopectinosis, consisting of intracellular glycogen inclusions, complicated by myopathy and cardiomyopathy, which have never previously been associated with any inborn error of immunity. These patients carry loss-of-function mutations in HOIL1 (also known as RBCK1), a component of the linear ubiquitination chain assembly complex (LUBAC). This E3 ligase complex, which adds head-to-tail linear polyubiquitin chains to substrate proteins, has been implicated in NF-κB signaling 16, 17 .
RESULTS

HOIL1 germ-line mutations in patients from two kindreds
The first kindred investigated (kindred A, French) was not consanguineous, but we nonetheless hypothesized that the two sisters (patients 1 and 2; (P1 and P2) suffered from an autosomal-recessive disorder ( Fig. 1a; case reports in Supplementary Note and Supplementary Fig. 1 ). We set out to decipher the underlying genetic defect by two genome-wide approaches: (i) use of a genome-wide human high-density single-nucleotide polymorphism (SNP) array (genome-wide investigations) to search for large genetic lesions, including copy-number variations (CNV) in particular and (ii) a whole-exome sequencing approach to search for small genetic lesions, including coding-gene variations in particular [18] [19] [20] . We identified no homozygous candidate lesion by either approach, suggesting that the two patients might be compound heterozygous. We therefore searched for heterozygous lesions in the same gene by genome-wide investigations and whole-exome sequencing. In both patients, we found a single-copy loss of 31.799 kilobases (kb) on chromosome 20p.13, encompassing the three last exons of TRIB3 and the first four exons of HOIL1 (Fig. 1b) . This deletion resulted from a genomic rearrangement owing to nonallelic homologous recombination between intron 1 of TRIB3 and intron 4 of HOIL1 (named TRIB3:g.-1272_HOIL1:g.9780del; Supplementary  Fig. 2a,b) . The lesion was inherited from the mother and was not transmitted to the healthy siblings. We identified no other mutation in TRIB3 by whole-exome sequencing or Sanger sequencing. By contrast, wholeexome sequencing and Sanger sequencing both showed that the two patients were heterozygous for the paternally derived nonsense p.Q185X (c.553C>T) mutation in exon 5 of HOIL1 (Fig. 1c) . 
A r t i c l e s
The second kindred investigated (kindred B, Italian) is consanguineous. The search for large genetic lesions by genome-wide investigations was not informative ( Fig. 1a; case report in Supplementary Note). By contrast, we identified a homozygous deletion of two nucleotides, cytosine and thymine at positions 121 and 122 (c.121_122delCT) in exon 2 of HOIL1 in the genome of patient 3 (P3) by whole-exome sequencing and confirmed this by Sanger sequencing. This deletion resulted in a frame shift and a premature stop codon (p.L41fsX7; Fig. 1d ). Genome-wide linkage and homozygosity mapping showed that the HOIL1 gene was located in a chromosomal region linked to the disease (data not shown). Both parents and one healthy sibling were heterozygous for the mutation. The three HOIL1 variants found in the two kindreds were not found in public databases (US National Center for Biotechnology Information dbSNP, University of California Santa Cruz genome browser and 1000 genomes) or in our own genome-wide investigation and whole-exome sequencing databases of 124 and 621 individuals, respectively. These variants were also absent from the data for the 392 individuals of the Centre d'Etude du Polymorphisme Humain-Human Genome Diversity Project (CEPH-HGDP) panel tested, suggesting that they are not irrelevant polymorphisms. HOIL1 encodes hemoxidized iron-regulatory protein 2 ubiquitin ligase 1 (HOIL-1). HOIL-1 is one of the components of the LUBAC, an E3 ligase complex that adds head-to-tail linear polyubiquitin chains to substrate proteins 16, 17 . The large deletion in HOIL-1 in P1 and P2 could lead, at the very least, to result in the deletion of the ubiquitin-like (Ubl) domain (assuming that translation is reinitiated; Fig. 1e ). The small nucleotide deletion in the gene in P3 was predicted to result in the deletion of all functional domains of HOIL-1. The nonsense mutation in P1 and P2 was predicted to result in premature truncation in the novel zinc finger (NZF) domain of HOIL-1. The Ubl domain is required for LUBAC formation and linear ubiquitination 16 . Collectively, these genetic data suggest that P1 and P2 from kindred A are compound heterozygous, and P3 from kindred B is homozygous, for rare deleterious alleles of HOIL1.
Impaired HOIL-1 expression in the patients' cells We assayed TRIB3 and HOIL1 mRNA by reverse transcriptionquantitative PCR (RT-qPCR) in SV40-immortalized fibroblasts from patients and controls. The amounts of TRIB3 mRNA were normal in the patients' cells (data not shown), whereas the amounts of HOIL1 mRNA were one-third to one-quarter those in the controls (Fig. 2a) . Similarly, TRIB3 protein was present in the patients' cells (Fig. 2b) , whereas HOIL-1 was undetectable by immunoblotting with antibodies to N-terminal (Fig. 2b) or C-terminal part of the protein (data not shown). HOIL-1 was also not detectable in Epstein-Barr virus (EBV)-immortalized B cell lines derived from P2 (data not shown). LUBAC is thought to consist of three protein subunits: HOIL-1, SHANK-associated RH domain-interacting protein (SHARPIN) and HOIL-1 interaction protein (HOIP, also known as RNF31) 16, 17, [21] [22] [23] [24] [25] . We thus assessed the abundance of these three components of LUBAC in fibroblasts. In cells from the three patients, SHARPIN protein amounts were about 50% lower than those in control cells and HOIP was almost undetectable (Fig. 2c) . It was therefore not possible to coimmunoprecipitate SHARPIN with HOIP in cells from P1 (Fig. 2d) . No lesion in HOIP or SHARPIN was detected by genome-wide investigations and whole-exome sequencing in the three patients. We then used fibroblasts from P1 and P2 to investigate whether the expression of a wild-type HOIL1 allele rescued LUBAC expression: HOIL-1 production was restored in the patients' cells by stable transfection with wild-type HOIL1 (Fig. 2e) . This expression of HOIL-1 also restored expression of the other two LUBAC components, HOIP and SHARPIN, to the amount observed in healthy controls (Fig. 2e ). These findings demonstrate that HOIL-1 is required for the overall stability of the LUBAC. Cells from the two compound heterozygous patients (P1 and P2) and from the patient homozygous for HOIL1 mutations (P3) therefore displayed HOIL-1 deficiency, resulting in a large decrease in the amounts of the other two molecules normally present in the LUBAC.
Impaired NF-kB activation in fibroblasts and B cells
It has been suggested that, at least on some cell types, the LUBAC regulates activation of the canonical NF-κB pathway, which has a key role in inflammatory and immune responses 16, 17, [22] [23] [24] [26] [27] [28] [29] . We therefore assessed the functionality of the canonical NF-κB pathway in SV40-immortalized fibroblasts from the patients. The lack of HOIL-1 in the patients' cells led to lower levels of IKK kinase phosphorylation, slower IκBα degradation and a decrease in NEMO ubiquitination in response to stimulation with either TNF or IL-1β (Fig. 3a,b) . By contrast, JNK phosphorylation in response to both stimuli was normal in the patients' fibroblasts (Fig. 3a,b) . The lower amounts Fig. 3a ). This impairment of the canonical NF-κB pathway led to weak induction of the NF-κB target genes IL6 and TNFAIP3 (also known as A20), which are normally induced by TNF or IL-1β ( Supplementary Fig. 3b ). Consistent with these RT-qPCR data, IL-6 production, as assessed by enzyme-linked immunosorbent assay (ELISA), in response to TNF or IL-1β treatment was weak in cells from the patients ( Fig. 3c and Supplementary Fig. 4a,b) , and the response to IL-1β treatment was more severely impaired than that to TNF treatment. The induction of the NF-κB target gene products, cellular inhibitors of apoptosis, was weaker in cells from P2 than in those from controls, and in response to stimulation with TNF we observed higher amounts of caspase-3 cleavage compared to the amounts in controls (Supplementary Fig. 4c ). These observations indicated that HOIL-1-deficient cells were more susceptible than controls to TNF-induced apoptosis. Introduction of wild-type HOIL-1 into fibroblasts from P1 restored IKK kinase phosphorylation, IκBα degradation and IL-6 secretion in response to both TNF and IL-1β treatment ( Fig. 3d-f ). This confirmed that the HOIL1 mutant alleles in the patients' fibroblasts were responsible for the impairment of the NF-κB response to both TNF and IL-1β. Analysis of IL-6 production in the patients' fibroblasts after stimulation with TLR2, TLR6 or TLR4 agonists indicated that these TLR pathways were also partially affected (Supplementary Fig. 4d ). IFN-β production after stimulation with the TLR3 agonist poly(I:C) was abolished in fibroblasts from the patients, whereas after stimulation of the RNA helicase RIG-I with 7SK-AS or poly(I:C) plus Lipofectamine resulted in normal IFN-β production ( Supplementary Fig. 4e ). Likewise, stimulation with R-848 (TLR7 and TLR8 agonist) did not induce TNF production in the patients' EBV-immortalized B cells ( Supplementary  Fig. 5a ). Finally, IKK phosphorylation and IκBα degradation in response to both IL-1β and CD40L were abolished in EBVimmortalized B cells from P2 ( Supplementary Fig. 5b,c) . Overall, NF-κB responses to all tested agonists of TNF receptor (TNFR), IL-1R and TLR family members were impaired in fibroblasts and EBV-immortalized B cells from patients with HOIL-1 deficiency.
Impaired NEMO recruitment to cytokine receptors
We investigated the molecular mechanisms underlying the defects in NF-κB activation in HOIL-1-deficient fibroblasts. It has been suggested that LUBAC regulates NF-κB activation by stabilizing the recruitment of the NEMO-IKK complex to the cytokine-activated receptor 23, 27, 28 . We therefore investigated the consequences of HOIL-1 deficiency for NEMO recruitment to the TNF and IL-1 receptor signaling complexes (RSCs). In control cells, NEMO was rapidly and transiently recruited to the RSCs, and we observed a clear enrichment in ubiquitinated NEMO species (Fig. 4a,b) . However, in cells from the HOIL-1-deficient patients, less NEMO was recruited to the TNF RSC (particularly for the ubiquitinated NEMO species; Fig. 4a) , and NEMO recruitment to the IL-1 RSC was almost entirely abolished (Fig. 4b) . SHARPIN recruitment to the RSCs was also reduced, especially in response to IL-1β (data not shown). We then investigated the association between NEMO and the polyubiquitinated npg adaptor RIP1 in response to TNF, and between NEMO and the polyubiquitinated adaptor IRAK-1 in response to IL-1β. Less NEMO was associated with ubiquitinated forms of RIP1 in patientderived than control fibroblasts, whereas the amount of polyubiquitinated RIP1 present in the TNF RSC was normal (Fig. 4c) . Similarly, the interaction between NEMO and ubiquitinated IRAK-1 in response to IL-1β was strongly impaired in the patients' cells, although the ubiquitination of IRAK-1 was unaffected (Fig. 4d) . Thus, the absence of HOIL-1 affects the recruitment or stability of NEMO-IKK complexes in response to both TNF and IL-1β, with the most severe defect being observed for the IL-1 RSC.
Genome-wide impact of HOIL-1 deficiency in fibroblasts
The above findings are generally consistent with the high incidence of opportunistic infections in the HOIL-1-deficient patients, which was similar to that of patients with impaired IL-1R-dependent and/or TNFR-dependent NF-κB immunity [5] [6] [7] [8] [9] [10] [11] 14 . However, unlike patients with these other immunodeficiencies, HOIL-1-deficient patients also presented with autoinflammation and amylopectinosis. We therefore investigated the effects of HOIL-1 deficiency on TNF and IL-1β responses, by analyzing the genome-wide transcriptional profiles (47,231 probes) of primary fibroblasts from four healthy controls, three HOIL-1-deficient patients (P1, P2 and P3), one MYD88-deficient patient and one NEMO-deficient (IKBKG-deficient) fetus. In control fibroblasts, 544 and 2,208 transcripts were regulated by IL-1β after 2 h and 6 h of stimulation, respectively, and 456 and 1,614 transcripts were regulated by TNF at the same time points (Fig. 5) . NEMO-deficient cells did not respond to either stimulus, whereas, as expected, MyD88-deficient cells responded to TNF but not to IL-1β. By contrast, HOIL-1-deficient cells were poorly responsive to IL-1β, as assessed after 2 h and 6 h; the response to TNF was almost identical to that of control cells after 2 h, but was weaker than that of control cells after 6 h. A more detailed analysis showed that control fibroblasts responded to IL-1β and TNF by the rapid induction of inflammatory cytokines, chemokines and cell-surface receptors (for example,
CCL5, CCL8, CXCL1, CXCL2, CXCL10, CXCR7, IL1β and TNFAIP3
(also known as A20) genes). The upregulation of these transcripts after 6 h of IL-1β stimulation was generally blunted in patients with HOIL-1 deficiency, although there were a few notable exceptions (for example, CCL2, CXCL1, IL8 and IL32). Thus, HOIL-1 deficiency in human fibroblast cells results in the impaired expression of NF-κB target genes in response to IL-1β and, to a lesser extent, TNF. The genome-wide transcriptome analysis data for fibroblasts were therefore consistent with the in vitro investigations described above and, in particular, with the receptor-recruitment data (Fig. 4a,b) : HOIL-1 deficiency and NEMO deficiency had many similarities, with only a few differences in terms of the fibroblast response to IL-1β, whereas the responses to TNF were more discordant.
Genome-wide impact of HOIL-1 deficiency in leukocytes
We studied the basis of autoinflammation in the patients further, by investigating their leukocytes ex vivo. We first investigated the consequences of HOIL-1 deficiency, by analyzing the genomewide transcriptional profiles of whole blood cells from P1 (without acute phase and free of infection) in the absence of stimulation. We compared the transcriptional profile of P1 with those of 41 healthy age-matched children and other patients with various genetically determined autoinflammatory disorders, including CAPS disorders (CINCA (2 patients) and MWS (5 patients) and MVK deficiency (2 patients). Blood cells from P1 had a unique gene expression profile ( Fig. 6a and Supplementary Fig. 6a,b) , with 2,900 transcripts upregulated or downregulated by a factor of at least two with respect to healthy controls. Transcripts encoding HOIL-1, IFN-γ and several members of the TNF family including CD30L (also known as TNFSF8) and APRIL (also known as TNFSF13) were downregulated by a factor of at least two. Transcripts encoding the proinflammatory cytokines IL-6, IL-6R and IL-6ST were upregulated in the patient's blood ex vivo (Supplementary Fig. 6b) . Genes belonging to networks involved in cell death, cell cycle, cell signaling, the inflammatory response, immune cell trafficking and carbohydrate metabolism were identified as being dysregulated in the patient. Using a pre-established framework of transcriptionally co-regulated transcripts, we demonstrated a distinct upregulation of erythroid lineagerelated and ubiquitination-related transcripts that differentiated the pattern of gene expression in the blood cells from this patient from those of patients with NLRP3 and MVK mutations (Supplementary Fig. 6a ). We also retrospectively studied the concentrations of inflammatory markers and cytokines in plasma samples collected from P1 and P2 at various ages. Consistent with the clinical phenotype, background concentrations of CRP and IL-6 were high, increasing further during each inflammatory episode (Fig. 6b) . The concentrations of other proinflammatory cytokines, including IL-8, TNF and IL-1β, and of some anti-inflammatory cytokines, notably of the IL-1R antagonist, were also high ( Fig. 6b and data not shown). Using ELISA, we then studied the production of cytokines by whole blood cells from P1 and P2 in response to stimulation (IL-1β, TLR agonists, two heat-killed pneumococcus strains and TNF). IL-1β and agonists of TLR1 and TLR2 induced IL-6 production in both patients more strongly than in healthy controls, whereas IL-10 production in response to treatment with TNF was abolished (Fig. 6c,d and Supplementary Fig. 6c) . Therefore, by contrast to the phenotype seen with fibroblasts, leukocytes from these two HOIL-1-deficient patients appeared to be both constitutively hyperinflammatory and hyperresponsive to IL-1β (but probably not TNF) ex vivo; this may explain, in part, the patients' autoinflammatory syndrome in vivo.
Hyperactivation of HOIL-1-deficient mononuclear leukocytes
We further investigated the inflammatory phenotype observed in whole blood cells from HOIL-1-deficient patients. We analyzed npg the genome-wide transcriptional profiles of peripheral blood mononuclear cells (PBMCs) from the three patients (P1, P2 and P3), three healthy controls (including two age-matched controls, C2 and C3) and two MyD88-deficient patients stimulated with TNF or IL-1β. The transcriptional profiles of PBMCs from HOIL-1-deficient patients, healthy controls and MyD88-deficient patients were similar after stimulation with TNF (Fig. 7a) . However, in response to IL-1β, HOIL-1-deficient PBMCs exhibited an overinduction, with respect to PBMCs from healthy controls, of transcription of 19 and 12 genes at 2 h and 6 h, respectively (Fig. 7a) . As expected, leukocytes from MyD88-deficient patients were unresponsive to IL-1β. The genes hyperinduced by IL-1β in HOIL-1-deficient cells included genes encoding proinflammatory cytokines IL6, MIP1A (also known as CCL3), MIP1B (also known as CCL4), IL8 and IL1B (Fig. 7b) . We then investigated which PBMC subsets were responsible for this hyper-response to IL-1β in HOIL-1-deficient patients. We stimulated PBMCs from P2, seven healthy controls and one IRAK-4-deficient patient with TNF, IL-1β, LPS or PMA plus ionomycin plus CpG-B. We identified the various PBMC subsets according to the cell-surface expression of the following markers: CD3 (T cells), CD19 (B cells), CD56 (NK cells) and CD14 (monocytes). We assessed the production of IL-6, IL-8, MIP-1α, MIP-1β, IL-1β and IFN-γ by intracellular staining and flow cytometry. In the CD3 + , CD19 + and CD56 + cells from control, HOIL-1-deficient and IRAK-4-deficient patients, we observed no response to TNF or IL-1β stimulation ( Supplementary Fig. 7a and data not shown). Upon stimulation with PMA plus ionomycin plus CpG-B, CD3 + cells from P2 produced large amounts of IL-8 (11% CD3 + IL-8 + versus 4% ± 3.8% in controls; ± s.d.), whereas IFN-γ was produced in smaller amounts (1% CD3 + IFN-γ + versus 15% ± 7.3%; Supplementary Fig. 7a ). Monocytes from P2 produced four times more IL-6 than those from healthy controls upon IL-1β stimulation, whereas IRAK-4-deficient monocytes were unresponsive ( Fig. 7c and Supplementary Fig. 7b ). Monocytes from P2 also produced large amounts of MIP-1α, but the levels of IL-8, IL-1β and MIP-1β production were similar to control values ( Fig. 7c and Supplementary Fig. 7a,b) . Finally, healthy controls and P2 monocytes responded similarly to LPS in terms of IL-6, IL-1β and MIP-1α production ( Fig. 7c and Supplementary Fig. 7a ). In conclusion, the hyper-response of whole blood and PBMCs from HOIL-1-deficient patients to IL-1β appears to be a consequence of the hyper-responsiveness of monocytes, probably accounting for the clinical autoinflammation in these patients.
DISCUSSION
We identified autosomal-recessive HOIL-1 deficiency as the cause of a new clinical entity combining invasive pyogenic bacterial infections, systemic autoinflammation and amylopectin-like deposits in muscle. HOIL-1, SHARPIN and HOIP are the three components of LUBAC 16, 17, [22] [23] [24] 27 . SHARPIN and HOIP protein amounts were low in the absence of HOIL-1, and their restoration after HOIL-1 expression suggests that LUBAC is a ternary complex. HOIP, the catalytic center of LUBAC 16, 17 , was almost undetectable in fibroblasts and B cells from HOIL-1-deficient patients, suggesting that these patients are LUBAC-deficient. LUBAC is involved in the NF-κB pathway and conjugates linear polyubiquitin chains onto specific lysine residues of NEMO 16 . HOIL-1-deficient human fibroblasts displayed impaired NF-κB activation, resulting in impaired NF-κB-driven gene transcription and cytokine production in response to TNF and IL-1β, consistent with data in mouse Hoil1 (Rbck1) knockdown or knockout cells 16, 27 . However, TNF-induced and IL-1β-induced JNK activity was normal in HOIL-1-deficient human fibroblasts, whereas TNFinduced JNK activity was enhanced in Hoil1 −/− mouse embryonic fibroblasts 16 . Overall, our results demonstrate that human HOIL-1 and LUBAC are required for TNF-induced and IL-1β-induced NF-κB responses, at least in fibroblasts. LUBAC facilitates the recruitment of the NEMO-IKK complex to cytokine receptors, in at least some cell types 23, 27, 28 . We showed that npg the recruitment of human NEMO to TNF RSCs and IL-1 RSCs was compromised in HOIL-1-deficient fibroblasts. LUBAC-mediated linear ubiquitination may facilitate the activation of IKK kinases; presumably, the attachment of linear ubiquitin chains to NEMO 16, 27 and, possibly, other components of the RSC 23 favors or stabilizes the incorporation of NEMO into the RSCs. The recognition of these linear ubiquitin chains by NEMO itself and, probably, by other components of the NF-κB cascade may then lead to a local accumulation of IKK kinases, favoring their trans-phosphorylation and activation. Alternatively, NEMO ubiquitination may induce a conformational change required for activation of the associated kinases. However, the amounts of NEMO ubiquitination in response to TNF or IL-1β in the patients' cells were only slightly lower than those in control cells, whereas the amount of ubiquitinated NEMO recruited to the TNFR or IL-1R correlated strongly with the signaling defect, as demonstrated by transcriptome analysis. Our findings also suggest that human LUBAC is required for optimal responses to other members of the TIR family, such as TLR3, and of the TNFR family, such as CD40. The susceptibility of these patients to invasive pyogenic bacterial disease is probably due to impaired NF-κB-dependent responses to at least some key members of the TIR and TNFR families in fibroblasts and, possibly, other cell types. Indeed, patients with inborn errors of NF-κB-mediated or TIR-mediated immunity, carrying IκBα, NEMO, IRAK-4 or MyD88 mutations, are also prone to pyogenic bacterial infections 6, 7, [9] [10] [11] 14 . The infectious phenotype of MyD88-deficient and IRAK-4-deficient patients is narrower than that of most patients with NEMO or IκBα mutations 6, 7, 9, 11, 14 . It may not be coincidental that IRAK-4-deficient, MyD88-deficient and HOIL-1-deficient patients have in common a profound lack of response to TIRs and predisposition to pyogenic bacterial diseases. One of the HOIL-1-deficient patients (P3) had a persistent cytomegalovirus infection, but it is unclear whether this was a consequence of HOIL-1 deficiency. Unlike most IRAK-4-deficient and MyD88-deficient patients, patients bearing mutations in NEMO and HOIL1 are deficient in memory B cells, and their antibody response to pneumococcal glycans is impaired. Two HOIL-1-deficient patients (P1 and P2) died before hematopoietic stem cell transplantation (HSCT) and the third (P3) died too soon after HSCT for any firm conclusions to be drawn about a possible hematopoietic origin of the predisposition to infection, as in patients with NEMO and IκBα mutations 14 . Similarly, Hoil1 −/− and spontaneous Sharpin-deficient (also known as Sharpin-chronic proliferative dermatitis (cpdm)) mice are uninformative on this issue, as neither has been challenged with pathogens 16, [22] [23] [24] 29 .
Bacterial infections in patients with mutations in IκBα, NEMO, IRAK-4 or MyD88 are associated with impaired inflammation [6] [7] [8] 11, 14, 30 , at odds with the case in HOIL-1-deficient patients, who displayed inflammation in the absence of overt infection. The autoinflammatory phenotype of our patients is consistent with that of their mononuclear leukocytes, monocytes in particular, which display constitutive over-transcription of many inflammatory genes and are hyper-responsive to IL-1β [1] [2] [3] . The hematopoietic origin of the autoinflammation in HOIL-1-deficient patients is supported by the fact that inflammation was controlled after HSCT in one HOIL-1-deficient patient. In the mouse, LUBAC seems to modulate inflammatory responses by regulating NF-κB activation directly 16, 17, 21, 23, [25] [26] [27] [28] and Hoil1-deficient mice display no apparent excessive inflammation 24 . However, Sharpin-cpdm mice [22] [23] [24] 29, 31 display severe eosinophilic inflammation and defective lymphoid organogenesis [22] [23] [24] [31] [32] [33] [34] . Consistent with this, the inflammatory disease in Sharpin-cpdm mice is partially rescued by inactivation of the Il1rap gene 34 , implicating IL-1β. The inflammatory phenotype of HOIL-1-deficient patients therefore resembles that of Sharpin-cpdm mice. Furthermore, inactivation of the TNF gene improves skin lesions in Sharpin-cpdm mice 23 and anti-TNF treatment in one HOIL-1-deficient patient reduced the clinical inflammation. This improvement might have resulted from a decrease in TNF-mediated IL-1β activity. Our study revealed that human HOIL-1 is anti-inflammatory: patients lacking HOIL-1 exhibited a strong autoinflammatory phenotype.
Autoinflammatory disorders may be complicated by metabolic disorders, and patients with TRAPS often develop amyloidosis (for example, refs. 1,3) . The HOIL-1-deficient patients displayed no amyloidosis, but had amylopectinosis, in the form of intracellular glycogen inclusions in their muscles. Amylopectinosis has not been reported in Sharpin-cpdm and Hoil1 −/− mice 16, [22] [23] [24] 32 . Several genetic etiologies of human amylopectinosis have been reported [35] [36] [37] [38] [39] [40] [41] . HOIL-1 deficiency is a new cause of amylopectinosis involving unknown mechanisms probably independent of IL-1, TNF and NF-κB, as amylopectinosis is not seen in other disorders associated with enhanced or impaired NF-κB immunity [6] [7] [8] 14 . In conclusion, the patients described here displayed a unique combination of clinical phenotypes, highlighting the important and complex role of the LUBAC in inflammation, immunity and metabolism in humans. The paradoxical association of autoinflammation and immunodeficiency probably results from an imbalance between cellular responses, to NF-κB-dependent proinflammatory stimuli at least, mediated by TIRs and TNFRs in particular. The molecular basis of the immunodeficiency may be impaired responses to inflammatory stimuli in fibroblasts and possibly other nonhematopoietic cell types, whereas the autoinflammation may result from enhanced responses to IL-1β in leukocytes, including monocytes in particular.
METHODS
Methods and any associated references are available in the online version of the paper.
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